Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant

Withdrawn before enrolling · Not applicable

Conditions studied: End Stage Renal Disease

In brief

This is a study of patients who have a high risk of kidney rejection before kidney transplant. The hypothesis is that treatment with a medication called rituximab will make it possible for them to receive a kidney transplant from a donor who previously did not present a good match.

Key facts

Study ID

NCT00167791

Run by

University of Wisconsin, Madison

People needed

0

Starts

2005-07-01

Expected to finish

2008-03-01

Last updated by the study team

2015-10-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Active status on a kidney transplant waiting list with positive cross match against a living donor

You may not qualify if…

• Receipt of a live vaccine within 4 weeks prior to randomization
• Previous Treatment with Rituximab

Where it is running

• University of Wisconsin — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.